BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akai H, Kiryu S, Matsuda I, Satou J, Takao H, Tajima T, Watanabe Y, Imamura H, Kokudo N, Akahane M. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT. Eur J Radiol. 2011;80:310-315. [PMID: 20732773 DOI: 10.1016/j.ejrad.2010.07.026] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Baek CK, Choi JY, Kim KA, Park MS, Lim JS, Chung YE, Kim MJ, Kim KW. Hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT. Clin Radiol. 2012;67:148-156. [PMID: 21920517 DOI: 10.1016/j.crad.2011.08.011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
2 Yu MH, Lee JM, Yoon J, Kiefer B, Han JK, Choi B. Clinical application of controlled aliasing in parallel imaging results in a higher acceleration (CAIPIRINHA)-volumetric interpolated breathhold (VIBE) sequence for gadoxetic acid-enhanced liver MR imaging: Controlled Aliasing in Parallel Imaging. J Magn Reson Imaging 2013;38:1020-6. [DOI: 10.1002/jmri.24088] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
3 Jia CK, Weng J, Chen YK, Fu Y. Anatomic resection of liver segments 6-8 for hepatocellular carcinoma. World J Gastroenterol 2014; 20(15): 4433-4439 [PMID: 24764684 DOI: 10.3748/wjg.v20.i15.4433] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
4 Girometti R. 3.0 Tesla magnetic resonance imaging: A new standard in liver imaging? World J Hepatol 2015; 7(15): 1894-1898 [PMID: 26244063 DOI: 10.4254/wjh.v7.i15.1894] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
5 Yu MH, Kim JH, Yoon J, Kim H, Chung JW, Han JK, Choi B. Small (≤1-cm) Hepatocellular Carcinoma: Diagnostic Performance and Imaging Features at Gadoxetic Acid–enhanced MR Imaging. Radiology 2014;271:748-60. [DOI: 10.1148/radiol.14131996] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 7.9] [Reference Citation Analysis]
6 Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, Kitai S, Hatanaka K, Yada N, Hagiwara S, Chung H, Sakurai T, Ueshima K, Sakamoto M, Maenishi O, Hyodo T, Okada M, Kumano S, Murakami T. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT. J Gastroenterol 2012;47:1036-47. [DOI: 10.1007/s00535-012-0571-6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
7 Takenaga T, Hanaoka S, Nomura Y, Nakao T, Shibata H, Miki S, Yoshikawa T, Hayashi N, Abe O. Multichannel three-dimensional fully convolutional residual network-based focal liver lesion detection and classification in Gd-EOB-DTPA-enhanced MRI. Int J Comput Assist Radiol Surg 2021;16:1527-36. [PMID: 34075548 DOI: 10.1007/s11548-021-02416-y] [Reference Citation Analysis]
8 Guo J, Seo Y, Ren S, Hong S, Lee D, Kim S, Jiang Y. Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis. Abdom Radiol (NY) 2016;41:1960-72. [PMID: 27318936 DOI: 10.1007/s00261-016-0807-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 9.5] [Reference Citation Analysis]
9 Akai H, Yasaka K, Nojima M, Inoue Y, Ohtomo K, Kiryu S. Influence of Indocyanine Green on Hepatic Gd-EOB-DTPA Uptake: A Proof-of-Concept Study in Mice. Invest Radiol 2017;52:441-5. [PMID: 28195848 DOI: 10.1097/RLI.0000000000000359] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Lee YJ, Lee JM, Lee JS, Lee HY, Park BH, Kim YH, Han JK, Choi BI. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology 2015;275:97-109. [PMID: 25559230 DOI: 10.1148/radiol.14140690] [Cited by in Crossref: 237] [Cited by in F6Publishing: 224] [Article Influence: 33.9] [Reference Citation Analysis]
11 Imbriaco M, De Luca S, Coppola M, Fusari M, Klain M, Puglia M, Mainenti P, Liuzzi R, Maurea S. Diagnostic Accuracy of Gd-EOB-DTPA for Detection Hepatocellular Carcinoma (HCC): A Comparative Study with Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced Computed Tomography (CT). Pol J Radiol. 2017;82:50-57. [PMID: 28217239 DOI: 10.12659/pjr.899239] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
12 Böttcher J, Hansch A, Pfeil A, Schmidt P, Malich A, Schneeweiss A, Maurer MH, Streitparth F, Teichgräber UK, Renz DM. Detection and classification of different liver lesions: comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation. Eur J Radiol. 2013;82:1860-1869. [PMID: 23932636 DOI: 10.1016/j.ejrad.2013.06.013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
13 Qu J, Han S, Zhang H, Liu H, Wang Z, Kamel IR, Berthold K, Dominik NM, Zhang S, Dong Y, Jiang L, Liu C, Li H. Improved Detection of Recurrent Hepatocellular Carcinomas in Arterial Phase With CAIPIRINHA-Dixon-TWIST-Volumetric Interpolated Breath-Hold Examination. Invest Radiol 2016;51:602-8. [DOI: 10.1097/rli.0000000000000281] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
14 Horowitz JM, Kamel IR, Arif-tiwari H, Asrani SK, Hindman NM, Kaur H, Mcnamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria ® Chronic Liver Disease. Journal of the American College of Radiology 2017;14:S391-405. [DOI: 10.1016/j.jacr.2017.08.045] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
15 Haradome H, Grazioli L, Tinti R, Morone M, Motosugi U, Sano K, Ichikawa T, Kwee TC, Colagrande S. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging. J Magn Reson Imaging. 2011;34:69-78. [PMID: 21598343 DOI: 10.1002/jmri.22588] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 7.2] [Reference Citation Analysis]
16 Takayama Y, Nishie A, Nakayama T, Asayama Y, Ishigami K, Kakihara D, Ushijima Y, Fujita N, Hirakawa M, Honda H. Hypovascular hepatic nodule showing hypointensity in the hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with chronic liver disease: Prediction of malignant transformation. European Journal of Radiology 2012;81:3072-8. [DOI: 10.1016/j.ejrad.2012.05.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
17 Kutara K, Seki M, Ishigaki K, Teshima K, Ishikawa C, Kagawa Y, Edamura K, Nakayama T, Asano K. Triple-phase helical computed tomography in dogs with solid splenic masses. J Vet Med Sci 2017;79:1870-7. [PMID: 28993600 DOI: 10.1292/jvms.17-0253] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
18 Ogawa M, Kawai T, Kan H, Kobayashi S, Akagawa Y, Suzuki K, Nojiri S, Ozawa Y, Shibamoto Y. Shortened breath-hold contrast-enhanced MRI of the liver using a new parallel imaging technique, CAIPIRINHA (controlled aliasing in parallel imaging results in higher acceleration): a comparison with conventional GRAPPA technique. Abdom Imaging 2015;40:3091-8. [PMID: 26099474 DOI: 10.1007/s00261-015-0491-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
19 Peng Z, Li C, Chan T, Cai H, Luo Y, Dong Z, Li ZP, Feng ST. Quantitative evaluation of Gd-EOB-DTPA uptake in focal liver lesions by using T1 mapping: differences between hepatocellular carcinoma, hepatic focal nodular hyperplasia and cavernous hemangioma. Oncotarget 2017;8:65435-44. [PMID: 29029443 DOI: 10.18632/oncotarget.18918] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
20 Liu X, Zou L, Liu F, Zhou Y, Song B. Gadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis. PLoS One. 2013;8:e70896. [PMID: 23967130 DOI: 10.1371/journal.pone.0070896] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
21 Yu MH, Kim JH, Yoon J, Kim H, Chung JW, Han JK, Choi B. Role of C-Arm CT for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Diagnostic Performance and Predictive Value for Therapeutic Response Compared With Gadoxetic Acid–Enhanced MRI. American Journal of Roentgenology 2013;201:675-83. [DOI: 10.2214/ajr.12.10445] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
22 Kutara K, Seki M, Ishikawa C, Sakai M, Kagawa Y, Iida G, Ishigaki K, Teshima K, Edamura K, Nakayama T, Asano K. TRIPLE-PHASE HELICAL COMPUTED TOMOGRAPHY IN DOGS WITH HEPATIC MASSES: Hepatic Contrast CT in Dogs. Veterinary Radiology & Ultrasound 2014;55:7-15. [DOI: 10.1111/vru.12099] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
23 Shiozawa K, Matsui T, Murakami T, Watanabe M, Maetani I. Predicting Therapeutic Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound. Diagnostics (Basel) 2021;11:291. [PMID: 33673221 DOI: 10.3390/diagnostics11020291] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kanata N, Yoshikawa T, Ohno Y, Kanda T, Uchida K, Izaki K, Fukumoto T, Ku Y, Itoh T, Kitajima K, Takahashi S, Sugimura K. HCC-to-liver contrast on arterial-dominant phase images of EOB-enhanced MRI: comparison with dynamic CT. Magnetic Resonance Imaging 2013;31:17-22. [DOI: 10.1016/j.mri.2012.06.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
25 You MW, Kim SY, Kim KW, Lee SJ, Shin YM, Kim JH, Lee MG. Recent advances in the imaging of hepatocellular carcinoma. Clin Mol Hepatol. 2015;21:95-103. [PMID: 25834808 DOI: 10.3350/cmh.2015.21.1.95] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
26 Leela-Arporn R, Ohta H, Shimbo G, Hanazono K, Osuga T, Morishita K, Sasaki N, Takiguchi M. Computed tomographic features for differentiating benign from malignant liver lesions in dogs. J Vet Med Sci 2019;81:1697-704. [PMID: 31597816 DOI: 10.1292/jvms.19-0278] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Nishie A, Kakihara D, Asayama Y, Ushijima Y, Takayama Y, Fujita N, Shimamoto D, Shirabe K, Hida T, Honda H. Detectability of hepatocellular carcinoma on gadoxetic acid-enhanced MRI at 3 T in patients with severe liver dysfunction: clinical impact of dual-source parallel radiofrequency excitation. Clinical Radiology 2015;70:254-61. [DOI: 10.1016/j.crad.2014.11.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
28 Semaan S, Vietti Violi N, Lewis S, Chatterji M, Song C, Besa C, Babb JS, Fiel MI, Schwartz M, Thung S, Sirlin CB, Taouli B. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid. Eur Radiol 2020;30:1020-30. [PMID: 31673837 DOI: 10.1007/s00330-019-06458-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
29 Bashir MR, Horowitz JM, Kamel IR, Arif-Tiwari H, Asrani SK, Chernyak V, Goldstein A, Grajo JR, Hindman NM, Kamaya A, McNamara MM, Porter KK, Solnes LB, Srivastava PK, Zaheer A, Carucci LR; Expert Panel on Gastrointestinal Imaging. ACR Appropriateness Criteria® Chronic Liver Disease. J Am Coll Radiol 2020;17:S70-80. [PMID: 32370979 DOI: 10.1016/j.jacr.2020.01.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Matos AP, Velloni F, Ramalho M, AlObaidy M, Rajapaksha A, Semelka RC. Focal liver lesions: Practical magnetic resonance imaging approach. World J Hepatol 2015; 7(16): 1987-2008 [PMID: 26261689 DOI: 10.4254/wjh.v7.i16.1987] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
31 Li J, Li X, Weng J, Lei L, Gong J, Wang J, Li Z, Zhang L, He S. Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging is more effective than enhanced 64-slice CT for the detection of small lesions in patients with hepatocellular carcinoma. Medicine (Baltimore) 2018;97:e13964. [PMID: 30593219 DOI: 10.1097/MD.0000000000013964] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Ye F, Liu J, Ouyang H. Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging and Multidetector-Row Computed Tomography for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Medicine (Baltimore) 2015;94:e1157. [PMID: 26266348 DOI: 10.1097/MD.0000000000001157] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
33 Li J, Wang J, Lei L, Yuan G, He S. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies. Eur Radiol 2019;29:6519-28. [PMID: 31250172 DOI: 10.1007/s00330-019-06294-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
34 Chen BB, Murakami T, Shih TT, Sakamoto M, Matsui O, Choi BI, Kim MJ, Lee JM, Yang RJ, Zeng MS, Chen RC, Liang JD. Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014). Liver Cancer 2015;4:215-27. [PMID: 26734577 DOI: 10.1159/000367742] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
35 Inokuchi Y, Uematsu M, Takashina T. Diagnostic accuracy of the attenuation value in abdominal contrast enhanced dynamic multi-detector-row computed tomography for esophageal varices in patients with liver cirrhosis. Eur J Radiol Open 2021;8:100347. [PMID: 33997144 DOI: 10.1016/j.ejro.2021.100347] [Reference Citation Analysis]
36 Cui E, Long W, Luo L, Hu M, Huang L, Chen X. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging. Acta Radiol 2017;58:1174-81. [PMID: 28090793 DOI: 10.1177/0284185116687170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
37 Kim KA, Kim MJ, Jeon HM, Kim KS, Choi JS, Ahn SH, Cha SJ, Chung YE. Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 2012;35:629-34. [PMID: 22069244 DOI: 10.1002/jmri.22876] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 7.6] [Reference Citation Analysis]
38 Cunha GM, Tamayo-murillo DE, Fowler KJ. LI-RADS and transplantation: challenges and controversies. Abdom Radiol 2021;46:29-42. [DOI: 10.1007/s00261-019-02311-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
39 Kim HD, Lim YS, Han S, An J, Kim GA, Kim SY, Lee SJ, Won HJ, Byun JH. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival. Gastroenterology. 2015;148:1371-1382. [PMID: 25733098 DOI: 10.1053/j.gastro.2015.02.051] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 9.7] [Reference Citation Analysis]
40 Schullian P, Johnston E, Laimer G, Putzer D, Eberle G, Westerlund P, Henninger B, Bale R. Thermal ablation of CT 'invisible' liver tumors using MRI fusion: a case control study. Int J Hyperthermia 2020;37:564-72. [PMID: 32484004 DOI: 10.1080/02656736.2020.1766705] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
41 Choi SH, Byun JH, Kwon H, Ha HI, Lee SJ, Kim SY, Won HJ, Kim P. The Usefulness of Gadoxetic Acid-Enhanced Dynamic Magnetic Resonance Imaging in Hepatocellular Carcinoma: Toward Improved Staging. Ann Surg Oncol 2015;22:819-25. [DOI: 10.1245/s10434-014-4074-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
42 Maiwald B, Lobsien D, Kahn T, Stumpp P. Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma? PLoS One. 2014;9:e111935. [PMID: 25375778 DOI: 10.1371/journal.pone.0111935] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
43 Jhaveri K, Cleary S, Audet P, Balaa F, Bhayana D, Burak K, Chang S, Dixon E, Haider M, Molinari M, Reinhold C, Sherman M. Consensus Statements From a Multidisciplinary Expert Panel on the Utilization and Application of a Liver-Specific MRI Contrast Agent (Gadoxetic Acid). American Journal of Roentgenology 2015;204:498-509. [DOI: 10.2214/ajr.13.12399] [Cited by in Crossref: 57] [Cited by in F6Publishing: 19] [Article Influence: 8.1] [Reference Citation Analysis]
44 Junqiang L, Yinzhong W, Li Z, Shunlin G, Xiaohui W, Yanan Z, Kehu Y. Gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: A meta-analysis: Gd-EOB-DTPA for the Detection of HCC. J Magn Reson Imaging 2014;39:1079-87. [DOI: 10.1002/jmri.24354] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
45 Ramalho M, Matos AP, AlObaidy M, Velloni F, Altun E, Semelka RC. Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 2. Radiol Bras 2017;50:115-25. [PMID: 28428655 DOI: 10.1590/0100-3984.2015.0140] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
46 Gyoda Y, Imamura H, Ichida H, Yoshimoto J, Ishizaki Y, Kuwatsuru R, Kawasaki S. Significance of hypovascular lesions on dynamic computed tomography and/or gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2019;34:1242-8. [PMID: 30345571 DOI: 10.1111/jgh.14510] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Kim AY, Kim YK, Lee MW, Park MJ, Hwang J, Lee MH, Lee JW. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis. Acta Radiol 2012;53:830-8. [DOI: 10.1258/ar.2012.120099] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
48 Takenaga T, Hanaoka S, Nomura Y, Nemoto M, Murata M, Nakao T, Miki S, Yoshikawa T, Hayashi N, Abe O. Four-dimensional fully convolutional residual network-based liver segmentation in Gd-EOB-DTPA-enhanced MRI. Int J Comput Assist Radiol Surg 2019;14:1259-66. [PMID: 30929130 DOI: 10.1007/s11548-019-01935-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
49 Barr DC, Hussain HK. Magnetic Resonance Imaging in Cirrhosis: What’s New? Topics in Magnetic Resonance Imaging 2014;23:129-49. [DOI: 10.1097/rmr.0000000000000017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Haradome H, Grazioli L, Al manea K, Tsunoo M, Motosugi U, Kwee TC, Takaraha T. Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection? J Magn Reson Imaging. 2012;35:132-139. [PMID: 21960465 DOI: 10.1002/jmri.22805] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
51 Bota S, Piscaglia F, Marinelli S, Pecorelli A, Terzi E, Bolondi L. Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma. Liver Cancer. 2012;1:190-200. [PMID: 24159584 DOI: 10.1159/000343833] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 7.0] [Reference Citation Analysis]
52 Schelhorn J, Best J, Reinboldt MP, Dechêne A, Gerken G, Ruhlmann M, Lauenstein TC, Antoch G, Kinner S. Does diffusion-weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd-EOB-DTPA with and without DWI: DWI in HCC Response Evaluation After RE. J Magn Reson Imaging 2015;42:818-27. [DOI: 10.1002/jmri.24827] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
53 Choi YR, Chung JW, Yu MH, Lee M, Kim JH. Diagnostic accuracy of contrast-enhanced dynamic CT for small hypervascular hepatocellular carcinoma and assessment of dynamic enhancement patterns: Results of two-year follow-up using cone-beam CT hepatic arteriography. PLoS One. 2018;13:e0203940. [PMID: 30231076 DOI: 10.1371/journal.pone.0203940] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
54 Shaw CM, Eisenbrey JR, Lyshchik A, O'kane PL, Merton DA, Machado P, Pino L, Brown DB, Forsberg F. Contrast-Enhanced Ultrasound Evaluation of Residual Blood Flow to Hepatocellular Carcinoma After Treatment With Transarterial Chemoembolization Using Drug-Eluting Beads: A Prospective Study. Journal of Ultrasound in Medicine 2015;34:859-67. [DOI: 10.7863/ultra.34.5.859] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
55 Zhao XT, Li WX, Chai WM, Chen KM. Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial? J Dig Dis. 2014;15:137-145. [PMID: 24354621 DOI: 10.1111/1751-2980.12119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
56 Kaneko R, Nakazaki N, Omori R, Yano Y, Ogawa M, Sato Y. The Effect of New Therapeutic and Diagnostic Agents on the Prognosis of Hepatocellular Carcinoma in Japan – An Analysis of Data from the Kanagawa Cancer Registry. Asian Pac J Cancer Prev 2017;18:2471-6. [PMID: 28952279 DOI: 10.22034/APJCP.2017.18.9.2471] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
57 Horowitz JM, Kamel IR, Arif-tiwari H, Asrani SK, Hindman NM, Kaur H, Mcnamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria ® Chronic Liver Disease. Journal of the American College of Radiology 2017;14:S103-17. [DOI: 10.1016/j.jacr.2017.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
58 Chen L, Zhang L, Liang M, Bao J, Zhang J, Xia Y, Huang X, Wang J. Magnetic Resonance Imaging with Gadoxetic Acid Disodium for the Detection of Hepatocellular Carcinoma. Academic Radiology 2014;21:1603-13. [DOI: 10.1016/j.acra.2014.08.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
59 Okajima W, Komatsu S, Ichikawa D, Miyamae M, Kawaguchi T, Hirajima S, Ohashi T, Imamura T, Kiuchi J, Arita T, Konishi H, Shiozaki A, Moriumura R, Ikoma H, Okamoto K, Taniguchi H, Itoh Y, Otsuji E. Circulating microRNA profiles in plasma: Identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function. Oncotarget. 2016;7:53820-53836. [PMID: 27462777 DOI: 10.18632/oncotarget.10781] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
60 Chou CT, Chen YL, Wu HK, Chen RC. Characterization of hyperintense nodules on precontrast T1-weighted MRI: utility of gadoxetic acid-enhanced hepatocyte-phase imaging. J Magn Reson Imaging. 2011;33:625-632. [PMID: 21563246 DOI: 10.1002/jmri.22500] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
61 Kakihara D, Nishie A, Harada N, Shirabe K, Tajima T, Asayama Y, Ishigami K, Nakayama T, Takayama Y, Okamoto D, Fujita N, Kishimoto J, Honda H. Performance of gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in recipients of living-related-liver-transplantation: comparison with dynamic multidetector row computed tomography and angiography-assisted computed tomography. J Magn Reson Imaging 2014;40:1112-20. [PMID: 24259437 DOI: 10.1002/jmri.24454] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
62 Erra P, Puglia M, Ragozzino A, Maurea S, Liuzzi R, Sabino G, Barbuto L, Cuocolo A, Imbriaco M. Appearance of hepatocellular carcinoma on gadoxetic acid-enhanced hepato-biliary phase MR imaging: a systematic review. Radiol Med. 2015;120:1002-1011. [PMID: 25900253 DOI: 10.1007/s11547-015-0539-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
63 Kudo M, Matsui O, Izumi N, Iijima H, Kadoya M, Imai Y, Okusaka T, Miyayama S, Tsuchiya K, Ueshima K, Hiraoka A, Ikeda M, Ogasawara S, Yamashita T, Minami T, Yamakado K; Liver Cancer Study Group of Japan. JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan. Liver Cancer 2014;3:458-68. [PMID: 26280007 DOI: 10.1159/000343875] [Cited by in Crossref: 274] [Cited by in F6Publishing: 272] [Article Influence: 39.1] [Reference Citation Analysis]
64 Akai H, Yasaka K, Nojima M, Kunimatsu A, Inoue Y, Abe O, Ohtomo K, Kiryu S. Gadoxetate disodium-induced tachypnoea and the effect of dilution method: a proof-of-concept study in mice. Eur Radiol 2018;28:692-7. [PMID: 28894937 DOI: 10.1007/s00330-017-5037-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
65 Andreou A, Vauthey JN, Cherqui D, Zimmitti G, Ribero D, Truty MJ, Wei SH, Curley SA, Laurent A, Poon RT, Belghiti J, Nagorney DM, Aloia TA; International Cooperative Study Group on Hepatocellular Carcinoma. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg. 2013;17:66-77; discussion p.77. [PMID: 22948836 DOI: 10.1007/s11605-012-2005-4] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 6.9] [Reference Citation Analysis]
66 Tan CH, Low SC, Thng CH. APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review. Int J Hepatol. 2011;2011:519783. [PMID: 22007313 DOI: 10.4061/2011/519783] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
67 Ooka Y, Kanai F, Okabe S, Ueda T, Shimofusa R, Ogasawara S, Chiba T, Sato Y, Yoshikawa M, Yokosuka O. Gadoxetic acid-enhanced MRI compared with CT during angiography in the diagnosis of hepatocellular carcinoma. Magn Reson Imaging. 2013;31:748-754. [PMID: 23218794 DOI: 10.1016/j.mri.2012.10.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
68 Sirlin CB, Hussain HK, Jonas E, Kanematsu M, Min Lee J, Merkle EM, Peck-Radosavljevic M, Reeder SB, Ricke J, Sakamoto M. Consensus report from the 6th International forum for liver MRI using gadoxetic acid. J Magn Reson Imaging. 2014;40:516-529. [PMID: 24923695 DOI: 10.1002/jmri.24419] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
69 Liu X, Zou L, Liu F, Zhou Y, Song B. Gadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis. PLoS One. 2013;8:e70896. [PMID: 23967130 DOI: 10.1371/journal.pone.0070896.ecolletion] [Cited by in F6Publishing: 1] [Reference Citation Analysis]